Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Anticancer Research|June 9, 2016
Bendamustin-Rituximab Combination Is a Safe and Effective, Ambulatory Treatment for Elderly Patients with Chronic Lymphocytic Leukemia: Retrospective Real-world Analysis by Age from a German Registry and Review of the LiteratureUlrich Richard Kleeberg, Hartmut Linde, Georg Günther, et al.
Advances in Colloid and Interface Science|January 25, 2014
Pattern formation and mass transfer under stationary solutal Marangoni instabilityKarin Schwarzenberger, Thomas Köllner, Hartmut Linde, et al.
International Journal of Cancer|July 15, 2018
Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinomaSusanna Hegewisch-Becker, Ali Aldaoud, Thomas Wolf, et al.
International Journal of Cancer|July 3, 2024
Head-to-head comparison of treatment sequences in advanced pancreatic cancer-Real-world data from the prospective German TPK clinical cohort studyNorbert Marschner, Nina Haug, Susanna Hegewisch-Becker, et al.
Annals of Hematology|March 13, 2024
Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practicesGeorg-Nikolaus Franke, Gunnar Loewe, Marcel Reiser, et al.
Annals of Hematology|June 26, 2023
Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study GroupJulia von Tresckow, Nikola Heyl, Sandra Robrecht, et al.
European Journal of Haematology|April 14, 2026
Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG RegistryNadine Kutsch, Rudy Ligtvoet, Sandra Robrecht, et al.
European Journal of Haematology|May 2, 2024
Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registryNadine Kutsch, Adam Giza, Sandra Robrecht, et al.
American Journal of Hematology|October 2, 2025
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA TrialKatja Sockel, Christoph Röllig, Anke Mütherig, et al.
Pageof 1